2023
DOI: 10.1007/s00604-023-05908-7
|View full text |Cite|
|
Sign up to set email alerts
|

Enantioseparation by zeolitic imidazolate framework-8-silica hybrid monolithic column with sulfobutylether-β-cyclodextrin as a chiral additive in capillary electrochromatography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 35 publications
0
0
0
Order By: Relevance
“…Co-solvents could provide a way to address the issue of insoluble drugs, but they also lead to change in permeability [12]. SBE-β-CD [13][14][15][16][17][18], a new pharmaceutical excipient often used as a co-solvent, has been included in USP44-NF39 under the name Betadex Sulfobutyl Ether Sodium, and is currently available as Captisol ® [19,20] and Dexolve ® [21]. It is widely used in biologics and insoluble drugs [22][23][24].…”
Section: Introductionmentioning
confidence: 99%
“…Co-solvents could provide a way to address the issue of insoluble drugs, but they also lead to change in permeability [12]. SBE-β-CD [13][14][15][16][17][18], a new pharmaceutical excipient often used as a co-solvent, has been included in USP44-NF39 under the name Betadex Sulfobutyl Ether Sodium, and is currently available as Captisol ® [19,20] and Dexolve ® [21]. It is widely used in biologics and insoluble drugs [22][23][24].…”
Section: Introductionmentioning
confidence: 99%